Derivation of normal macrophages from human embryonic stem (hES) cells for applications in HIV gene therapy
2006

Creating Normal Macrophages from Human Embryonic Stem Cells for HIV Research

publication Evidence: moderate

Author Information

Author(s): Anderson Joseph S, Bandi Sriram, Kaufman Dan S, Akkina Ramesh

Primary Institution: Colorado State University

Hypothesis

Can human embryonic stem cell-derived CD34 cells give rise to normal macrophages that are susceptible to HIV infection?

Conclusion

Normal and functional macrophages can be derived from human embryonic stem cells, which can be used for HIV infection studies.

Supporting Evidence

  • Macrophages derived from hES-CD34 cells showed normal surface markers and functional characteristics.
  • These macrophages supported productive HIV-1 infection, indicating their utility for HIV research.
  • Transduced hES cells did not exhibit adverse effects during differentiation into macrophages.

Takeaway

Scientists can make healthy immune cells called macrophages from special stem cells, and these cells can get infected by HIV, which helps in studying the virus.

Methodology

Human embryonic stem cells were cultured to derive CD34 hematopoietic progenitor cells, which were then differentiated into macrophages and analyzed for their phenotypic and functional characteristics.

Limitations

The study does not address the long-term effects of using hES-derived cells in therapeutic applications.

Digital Object Identifier (DOI)

10.1186/1742-4690-3-24

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication